Panel discussion: evolving best practices in high-complexity flow cytometry

What will you learn?

•  Receive a primer on the basics of conventional and spectral flow cytometry
•  Understand best practices for instrument maintenance and standardization
•  Understand the advancements and advantages of spectral flow
•  Consider how investing time in robust panel development can have broad application to your research

Who this may interest?

Researchers and procurement professionals looking to:

• Learn more about conventional versus spectral flow
• Understand practical tips to trouble-shoot their assays
• Stay current with the evolving best practices in this rapidly advancing field

Speakers

David Ambrose, MBA, SCYM (ASCP)

Associate Director, Flow Cytometry

KCAS Bio (PA, USA)

David is currently an Associate Director of Flow Cytometry at KCAS Bio. He has nearly 20 years of experience utilizing flow cytometry techniques, including more than 15 years in both core labs and CROs. David possesses a wealth of experience in cell therapy development, high-complexity instrument operation and high-dimensional flow cytometry analysis. He completed his education and initial training at Temple University and the University of Pennsylvania and continues his work out of the new KCAS Bio facility in Philadelphia (both PA, USA).

Dr Maria Jaimes

Vice President, Scientific Commercialization

Cytek® Biosciences (CA, USA)

Maria Jaimes is the VP of Scientific Commercialization at Cytek® Biosciences and was part of the original team that developed and launched the Cytek Aurora Full Spectrum Cytometer. Maria earned her MD degree at the Universidad Javeriana (Bogota, Colombia), and received her postdoctoral degree from the Microbiology and Immunology department at Stanford University (CA, USA). Maria has over 15 years of industry experience in the field of flow cytometry and has helped define best practices for various aspects of quality assurance and standardization of flow cytometry assays, including instrument performance and setup. Additionally, she has used her extensive experience in immunology and multicolor flow to leverage the benefits of full-spectrum cytometry and is one of the authors of OMIP-069, the first publication featuring a 40-color laser-based flow cytometry panel.

Dr Mike Blundell

Global Product Manager, StarBright Dyes

Bio-Rad Laboratories (CA, USA)

Mike Blundell graduated from the University of Edinburgh (UK) with a BSc (Hons) in Immunology. He then moved to University College London where he joined the group of Professor Adrian Thrasher and obtained his PhD. His thesis research focused on the primary immunodeficiency Wiskott Aldrich Syndrome and he contributed to over 50 peer-reviewed papers. He investigated novel activating mutations and developed lentiviral vectors for use in gene therapy treatments, which have now been successfully used in clinical trials. Mike left academia in 2015 to become a Product Manager for Flow Cytometry Reagents at Bio-Rad.